Refine
Year of publication
Document Type
- Article (87)
- Contribution to a Periodical (4)
- Preprint (2)
- Part of a Book (1)
Has Fulltext
- yes (94)
Is part of the Bibliography
- no (94)
Keywords
- NMR spectroscopy (14)
- SARS-CoV-2 (11)
- RNA (10)
- COVID19-NMR (5)
- G-quadruplexes (4)
- NMR (4)
- Solution NMR spectroscopy (4)
- Solution NMR-spectroscopy (4)
- rna (4)
- structural biology (4)
- 5′-UTR (3)
- Covid19-NMR (3)
- Mycobacterium tuberculosis (3)
- Non-structural protein (3)
- Protein drugability (2)
- RNA structures (2)
- aptamers (2)
- base pairing (2)
- biophysics (2)
- heteronuclear detection (2)
- kinetics (2)
- nuclear magnetic resonance spectroscopy (2)
- proteins (2)
- proteomics (2)
- reactive oxygen species (2)
- real-time NMR spectroscopy (2)
- small protein (2)
- small proteins (2)
- structure elucidation (2)
- 19F (1)
- 19F MR spectroscopy (1)
- 1H MR spectroscopy (1)
- 2'-deoxyguanosine riboswitch (1)
- 2-hydroxyglutarate (1)
- 2D NMR spectroscopy (1)
- 5'-UTR (1)
- 5_SL4 (1)
- ATG3 (1)
- B. subtilis (1)
- Bacterial Protein Kinases (1)
- Bacterial Protein Phosphatases (1)
- Biochemie (1)
- Biotin (1)
- Bradyrhizobium (1)
- C-mannosylation (1)
- CEST (1)
- COVID-19 (1)
- Covid19-nmr (1)
- DNA (1)
- DNA-PAINT (1)
- DNA-ligand complexes (1)
- Dimerization domain (1)
- Direct carbon (1)
- Drug Resistance (1)
- Drug discovery (1)
- Dynamische Kernpolarisation (1)
- E. coli (1)
- Echtzeit-NMR-Spektroskopie (1)
- Empfindlichkeitsverstärkung (1)
- Eph receptors (1)
- Ephrin ligand (1)
- Esters (1)
- Eukaryota (1)
- FBDD (1)
- FBS (1)
- FGFR (1)
- Fragment (1)
- G-protein-coupled receptors (1)
- G-quadruplex binders (1)
- Haloferax volcanii (1)
- HeLa cells (1)
- High-throughput screening (1)
- Hohes Magnetfeld (1)
- IDH mutation (1)
- IDH1 inhibitor (1)
- Internal ribosome entry site (1)
- Ligands (1)
- Low Molecular Weight PTP (1)
- Luciferase (1)
- Macrodomain (1)
- Methanosarcina mazei (1)
- Molecular modelling (1)
- MptpA (1)
- NMR Spectroscopy (1)
- NMR solution structure (1)
- NMR-Spektroskopie (1)
- NOESY (1)
- Nuclear magnetic resonance (1)
- Nucleic acid-binding domain (1)
- Nucleocapsid (1)
- Personalisierte Medizin (1)
- Phosphorylation (1)
- Primary metabolites (1)
- Protein druggability (1)
- Protein translation (1)
- PtkA (1)
- Quality control (1)
- RNA genome (1)
- RNA sequencing (RNA-Seq) (1)
- RNA stability (1)
- RNA synthesis (1)
- RNA therapy (1)
- RNASolution-state NMR (1)
- SHAPE analysis (1)
- SL1 (1)
- SL5a (1)
- SL5b (1)
- SL5b + c (1)
- SL5c (1)
- SSR128129E (1)
- Secondary metabolites (1)
- Shine-Dalgarno (1)
- Sinorhizobium fredii (1)
- Solubility (1)
- Solution-state NMR (1)
- Soybean (1)
- Stoffwechsel (1)
- Structural protein (1)
- TERRA RNA (1)
- Target validation (1)
- Translation initiation (1)
- UV/Vis spectroscopy (1)
- X-ray diffraction (1)
- Zellstudien (1)
- a-proteobacteria (1)
- accessory proteins (1)
- acute myeloid leukemia (1)
- adenine (1)
- alkylation (1)
- allostery (1)
- amino acids (1)
- analysis (1)
- analytical chemistry (1)
- antibiotics (1)
- autophagy (1)
- autophagy inhibition (1)
- barstar (1)
- biochemistry (1)
- biological chemistry (1)
- biological models (1)
- biophysical investigation (1)
- c-Myc (1)
- carbazole ligands (1)
- carbon direct detection (1)
- cell death (1)
- cell studies (1)
- cell-free protein synthesis (1)
- chemoenzymatic synthesis (1)
- chronic myeloid leukemia (1)
- circular dichroism (1)
- click chemistry (1)
- colorectal cancer (1)
- computational chemistry (1)
- conformation analysis (1)
- cysteine reactivity (1)
- cysteine-redox regulation (1)
- cytochromes (1)
- detection (1)
- diagnostic radiologic examination (1)
- drug design (1)
- entropy (1)
- eph receptor tyrosin kinase family (1)
- ephrins (1)
- fluorescence (1)
- fluorine (1)
- folding (1)
- folding landscapes (1)
- fragment screening (1)
- fragment-based screening (1)
- genetic code expansion (1)
- glioma (1)
- glutamine synthetase regulation (1)
- glutathione (1)
- glutathionylation (1)
- glycoproteins (1)
- guanidine riboswitch (1)
- hydroxynaphthoquinone (1)
- inhibitor (1)
- inhibitor design (1)
- intrinsically disordered protein (1)
- intrinsically disordered region (1)
- ions (1)
- isotope labeling (1)
- large functional RNAs (1)
- ligand design (1)
- ligands (1)
- ligases (1)
- light control (1)
- meta-stable structures (1)
- metabolic reprogramming (1)
- metabolic rewiring (1)
- metabolism (1)
- metals (1)
- molecular conformation (1)
- murine model (1)
- nitrogen direct detection (1)
- nitrogen regulation (1)
- nitroindoles (1)
- nitrosylation (1)
- non-canonical amino acid (1)
- non-natural nucleotide (1)
- nonstructural proteins (1)
- nucleobases (1)
- oligonucleotides (1)
- oncogene promoters (1)
- oxidases (1)
- oxidative folding (1)
- personalized medicine (1)
- photochemistry (1)
- plant symbioses (1)
- plasmid copy number (1)
- precision (1)
- proline isomerization (1)
- protein denaturation (1)
- protein folding (1)
- protein oxidation (1)
- protein phosphorylation (1)
- protein tyrosine kinase (1)
- protein tyrosine phosphatase (1)
- protons (1)
- quorum sensing (QS) (1)
- reductases (1)
- regioisomers (1)
- retinal (1)
- rhodopsin (1)
- ribosomal binding site (1)
- ribosomal exit tunnel (1)
- ribosome (1)
- riboswitches (1)
- ribozymes (1)
- roentgen rays (1)
- sORF (1)
- salmonella (1)
- selective isotopic labeling (1)
- site-specific labeling (1)
- small ORFs (1)
- small gene (1)
- small molecule inhibitor (1)
- solid-phase synthesis (1)
- spectrum (1)
- spectrum analysis (1)
- structural proteins (1)
- structure-activity relationships (1)
- structure–activity relationships (1)
- targeted therapy (1)
- temperature (1)
- temperature jump (1)
- thermometers (1)
- thiostrepton (1)
- transcription (1)
- transient complex (1)
- translation initiation region (1)
- tumor angiogenesis (1)
- tumor hypoxia (1)
- tumor perfusion (1)
- tyrosine kinase inhibitors (1)
- tyrosine kinase inhibitors. (1)
- tyrosine kinase signaling (1)
- zinc finger (1)
- µ-protein (1)
Institute
- Biochemie und Chemie (47)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (44)
- Biochemie, Chemie und Pharmazie (35)
- Exzellenzcluster Makromolekulare Komplexe (23)
- Sonderforschungsbereiche / Forschungskollegs (23)
- Biowissenschaften (19)
- Medizin (7)
- Präsidium (4)
- Georg-Speyer-Haus (3)
- Frankfurt Institute for Advanced Studies (FIAS) (1)
Despite the great interest in glycoproteins, structural information reporting on conformation and dynamics of the sugar moieties are limited. We present a new biochemical method to express proteins with glycans that are selectively labeled with NMR‐active nuclei. We report on the incorporation of 13C‐labeled mannose in the C‐mannosylated UNC‐5 thrombospondin repeat. The conformational landscape of the C‐mannose sugar puckers attached to tryptophan residues of UNC‐5 is characterized by interconversion between the canonical 1C4 state and the B03 / 1S3 state. This flexibility may be essential for protein folding and stabilization. We foresee that this versatile tool to produce proteins with selectively labeled C‐mannose can be applied and adjusted to other systems and modifications and potentially paves a way to advance glycoprotein research by unravelling the dynamical and conformational properties of glycan structures and their interactions.
Telomeric G-quadruplexes have recently emerged as drug targets in cancer research. Herein, we present the first NMR structure of a telomeric DNA G-quadruplex that adopts the biologically relevant hybrid-2 conformation in a ligand-bound state. We solved the complex with a metalorganic gold(III) ligand that stabilizes G-quadruplexes. Analysis of the free and bound structures reveals structural changes in the capping region of the G-quadruplex. The ligand is sandwiched between one terminal G-tetrad and a flanking nucleotide. This complex structure involves a major structural rearrangement compared to the free G-quadruplex structure as observed for other G-quadruplexes in different conformations, invalidating simple docking approaches to ligand-G-quadruplex structure determination
The ribosomal S1 protein (rS1) is indispensable for translation initiation in Gram-negative bacteria. rS1 is a multidomain protein that acts as an RNA chaperone and ensures that mRNAs can bind the ribosome in a single-stranded conformation, which could be related to fast recognition. Although many ribosome structures were solved in recent years, a high-resolution structure of a two-domain mRNA-binding competent rS1 construct is not yet available. Here, we present the NMR solution structure of the minimal mRNA-binding fragment of Vibrio Vulnificus rS1 containing the domains D3 and D4. Both domains are homologues and adapt an oligonucleotide-binding fold (OB fold) motif. NMR titration experiments reveal that recognition of miscellaneous mRNAs occurs via a continuous interaction surface to one side of these structurally linked domains. Using a novel paramagnetic relaxation enhancement (PRE) approach and exploring different spin-labeling positions within RNA, we were able to track the location and determine the orientation of the RNA in the rS1–D34 bound form. Our investigations show that paramagnetically labeled RNAs, spiked into unmodified RNA, can be used as a molecular ruler to provide structural information on protein-RNA complexes. The dynamic interaction occurs on a defined binding groove spanning both domains with identical β2-β3-β5 interfaces. Evidently, the 3′-ends of the cis-acting RNAs are positioned in the direction of the N-terminus of the rS1 protein, thus towards the 30S binding site and adopt a conformation required for translation initiation.
Genetic code expansion facilitates position-selective modification of nucleic acids and proteins
(2020)
Transcription and translation obey to the genetic code of four nucleobases and 21 amino acids evolved over billions of years. Both these processes have been engineered to facilitate the use of non-natural building blocks in both nucleic acids and proteins, enabling researchers with a decent toolbox for structural and functional analyses. Here, we review the most common approaches for how labeling of both nucleic acids as well as proteins in a site-selective fashion with either modifiable building blocks or spectroscopic probes can be facilitated by genetic code expansion. We emphasize methodological approaches and how these can be adapted for specific modifications, both during as well as after biomolecule synthesis. These modifications can facilitate, for example, a number of different spectroscopic analysis techniques and can under specific circumstances even be used in combination.
The formation of oligomers of the amyloid-β peptide plays a key role in the onset of Alzheimer's disease. We describe herein the investigation of disease-relevant small amyloid-β oligomers by mass spectrometry and ion mobility spectrometry, revealing functionally relevant structural attributes. In particular, we can show that amyloid-β oligomers develop in two distinct arrangements leading to either neurotoxic oligomers and fibrils or non-toxic amorphous aggregates. Comprehending the key-attributes responsible for those pathways on a molecular level is a pre-requisite to specifically target the peptide's tertiary structure with the aim to promote the emergence of non-toxic aggregates. Here, we show for two fibril inhibiting ligands, an ionic molecular tweezer and a hydrophobic peptide that despite their different interaction mechanisms, the suppression of the fibril pathway can be deduced from the disappearance of the corresponding structure of the first amyloid-β oligomers.
Fragment-based screening has evolved as a remarkable approach within the drug discovery process both in the industry and academia. Fragment screening has become a more structure-based approach to inhibitor development, but also towards development of pathway-specific clinical probes. However, it is often witnessed that the availability, immediate and long-term, of a high quality fragment-screening library is still beyond the reach of most academic laboratories. Within iNEXT (Infrastructure for NMR, EM and X-rays for Translational research), a EU-funded Horizon 2020 program, a collection of 782 fragments were assembled utilizing the concept of “poised fragments” with the aim to facilitate downstream synthesis of ligands with high affinity by fragment ligation. Herein, we describe the analytical procedure to assess the quality of this purchased and assembled fragment library by NMR spectroscopy. This quality assessment requires buffer solubility screening, comparison with LC/MS quality control and is supported by state-of-the-art software for high throughput data acquisition and on-the-fly data analysis. Results from the analysis of the library are presented as a prototype of fragment progression through the quality control process.
The C40A/C82A double mutant of barstar has been shown to undergo cold denaturation above the water freezing point. By rapidly applying radio-frequency power to lossy aqueous samples, refolding of barstar from its cold-denatured state can be followed by real-time NMR spectroscopy. Since temperature-induced unfolding and refolding is reversible for this double mutant, multiple cycling can be utilized to obtain 2D real-time NMR data. Barstar contains two proline residues that adopt a mix of cis and trans conformations in the low-temperature-unfolded state, which can potentially induce multiple folding pathways. The high time resolution real-time 2D-NMR measurements reported here show evidence for multiple folding pathways related to proline isomerization, and stable intermediates are populated. By application of advanced heating cycles and state-correlated spectroscopy, an alternative folding pathway circumventing the rate-limiting cis-trans isomerization could be observed. The kinetic data revealed intermediates on both, the slow and the fast folding pathway.
Polymorphic G-quadruplex (G4) secondary DNA structures have received increasing attention in medicinal chemistry owing to their key involvement in the regulation of the maintenance of genomic stability, telomere length homeostasis and transcription of important proto-oncogenes. Different classes of G4 ligands have been developed for the potential treatment of several human diseases. Among them, the carbazole scaffold with appropriate side chain appendages has attracted much interest for designing G4 ligands. Because of its large and rigid π-conjugation system and ease of functionalization at three different positions, a variety of carbazole derivatives have been synthesized from various natural or synthetic sources for potential applications in G4-based therapeutics and biosensors. Herein, we provide an updated close-up of the literatures on carbazole-based G4 ligands with particular focus given on their detailed binding insights studied by NMR spectroscopy. The structure-activity relationships and the opportunities and challenges of their potential applications as biosensors and therapeutics are also discussed. This review will provide an overall picture of carbazole ligands with remarkable G4 topological preference, fluorescence properties and significant bioactivity; portraying carbazole as a very promising scaffold for assembling G4 ligands with a range of novel functional applications.
We report here the in-cell NMR-spectroscopic observation of the binding of the cognate ligand 2′-deoxyguanosine to the aptamer domain of the bacterial 2′-deoxyguanosine-sensing riboswitch in eukaryotic cells, namely Xenopus laevis oocytes and in human HeLa cells. The riboswitch is sufficiently stable in both cell types to allow for detection of binding of the ligand to the riboswitch. Most importantly, we show that the binding mode established by in vitro characterization of this prokaryotic riboswitch is maintained in eukaryotic cellular environment. Our data also bring important methodological insights: Thus far, in-cell NMR studies on RNA in mammalian cells have been limited to investigations of short (<15 nt) RNA fragments that were extensively modified by protecting groups to limit their degradation in the intracellular space. Here, we show that the in-cell NMR setup can be adjusted for characterization of much larger (≈70 nt) functional and chemically non-modified RNA.
The respiratory chain of Escherichia coli contains two different types of terminal oxidase that are differentially regulated as a response to changing environmental conditions. These oxidoreductases catalyze the reduction of molecular oxygen to water and contribute to the proton motive force. The cytochrome bo3 oxidase (cyt bo3) acts as the primary terminal oxidase under atmospheric oxygen levels, whereas the bd‐type oxidase is most abundant under microaerobic conditions. In E. coli, both types of respiratory terminal oxidase (HCO and bd‐type) use ubiquinol‐8 as electron donor. Here, we assess the inhibitory potential of newly designed and synthesized 3‐alkylated Lawson derivatives through L‐proline‐catalyzed three‐component reductive alkylation (TCRA). The inhibitory effects of these Lawson derivatives on the terminal oxidases of E. coli (cyt bo3 and cyt bd‐I) were tested potentiometrically. Four compounds were able to reduce the oxidoreductase activity of cyt bo3 by more than 50 % without affecting the cyt bd‐I activity. Moreover, two inhibitors for both cyt bo3 and cyt bd‐I oxidase could be identified. Based on molecular‐docking simulations, we propose binding modes of the new Lawson inhibitors. The molecular fragment benzyl enhances the inhibitory potential and selectivity for cyt bo3, whereas heterocycles reduce this effect. This work extends the library of 3‐alkylated Lawson derivatives as selective inhibitors for respiratory oxidases and provides molecular probes for detailed investigations of the mechanisms of respiratory‐chain enzymes of E. coli.